Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
199.30    2.60 (1.32%)
Bid:
199.00
Ask:
199.30
Spread: 0.30 (0.151%)
Market Cap: £2.00b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Ordinary General Meeting

2 Aug 2018 07:00

RNS Number : 5126W
B&M European Value Retail S.A.
02 August 2018
 

 

 

02 August 2018

 

B&M European Value Retail S.A.

 

Notice of Ordinary General Meeting

 

B&M European Value Retail S.A. (the "Company"), the UK's leading general merchandise value retailer, announces that it has posted to shareholders today Notice of an Ordinary General Meeting of the Company.

 

The Ordinary General Meeting will be held at on Tuesday 18 September 2018 at Le Royal Hotel, 12, Boulevard Royal, L-2449 Luxembourg, commencing at 10:00 am (CET).

 

The purpose of the Ordinary General Meeting is to propose that Tiffany Hall be appointed as a Non-Executive Director of the Company.

 

The Notice of the Ordinary General Meeting, is available on the Company's website at www.bandmretail.com/investors/ogm.aspx

 

A summary form of the Notice of the Ordinary General Meeting is set out in Appendix 1 to this announcement.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Daniel Yea

bmstores-maitland@maitland.co.uk

 

 

 

APPENDIX 1

 

B&M European Value Retail S.A.

Société Anonyme

Registered office: 9, Allée Scheffer, L-2520 Luxembourg

Grand-Duchy of Luxembourg

R.C.S. Luxembourg: B 187275

 

Notice of the Ordinary General Meeting of B&M European Value Retail S.A. to be held at 10:00 am (CET) on Tuesday 18 September 2018 at Le Royal Hotel, 12, Boulevard Royal, L-2449 Luxembourg.

 

AGENDA

1. To appoint Tiffany Hall as a Director of the Company with immediate effect until the Annual General Meeting resolving on the financial statements for the financial year ended 31 March 2019.

 

Explanation of Business to be considered at the Extraordinary General Meeting

 

Resolution: Appointment of Non-Executive Director

The Board of Directors (the "Board") of B&M European Value Retail S.A. ("B&M" or the "Company") presently has seven members, comprising the Non-Executive Chairman, two Executive Directors and four Independent Non-Executive Directors. As the business in the Company's group continues to grow at a significant rate and also as part of succession planning generally looking to the future, the Board considers that there is a requirement for further non-executive director appointments to be made in the meantime.

 

Following a search undertaken by Russell Reynolds Associates on behalf of the Nomination Committee of the Company and a series of interviews, the Nomination Committee has recommended that Tiffany Hall be appointed as a Non-Executive Director to the Board of B&M. The Board has unanimously resolved to propose that Tiffany be appointed with immediate effect to the Board by the ordinary general meeting of shareholders of the Company.

 

Tiffany Hall has a strong background in marketing, sales and customer services. She previously served as Managing Director of BUPA Home Healthcare, Marketing Director at BUPA, Head of Marketing at British Airways and also Chair of Airmiles and BA Holidays. Prior to that she held other positions at British Airways including Head of Global Sales and Distribution and Head of UK Sales and Marketing. She has also previously been a Non-Executive Director of Think London.

 

Tiffany is currently the Senior Independent Director and Chair of the Remuneration Committee of Howden Joinery Group Plc ("Howden"). She originally joined the Board of Howden as a Non-Executive Director in May 2010.

 

Notes 

 

Quorum and voting

In accordance with Article 24.6 of the Articles of Association of the Company, all decisions taken at the Meeting will be passed by a simple majority of the votes cast on the resolution, regardless of the proportion of issued ordinary share capital represented by shareholders at the Meeting. Each holder of ordinary shares has one vote in respect of each ordinary share held. As a result, the quorum for the Meeting is at least one shareholder present in person or by proxy.

 

Total voting rights

As at 1 August 2018 (being the last business day prior to the publication of this notice) the Company's issued ordinary share capital consists of 1,000,561,222 (one billion five hundred and sixty-one thousand two hundred and twenty two) ordinary shares, carrying one vote each. The Company holds no treasury shares, therefore the total voting rights in the Company as at 1 August 2018 is 1,000,561,222 (one billion five hundred and sixty-one thousand two hundred and twenty two).

 

Poll

All items in the Notice of the Ordinary General Meeting will be decided by a poll of shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOGGMGGRFMVGRZM
Date   Source Headline
9th Dec 20244:00 pmRNSDirector Purchase of Shares
22nd Nov 20244:02 pmRNSDirector Exercise of Share Options
22nd Nov 20244:00 pmRNSDirector Purchase of Shares
19th Nov 20244:52 pmRNSPricing of £250 Million Senior Secured Notes
18th Nov 20248:00 amRNSLaunch of £250 million Senior Secured Notes Offer
14th Nov 20247:00 amRNSFY25 Interim Results
31st Oct 20241:00 pmRNSTiming of Announcement of Interim Results
17th Oct 20243:00 pmRNSTR1: Notification of Major Holding in Company
4th Oct 20245:30 pmRNSDirector Declaration
30th Sep 20242:15 pmRNSTotal Voting Rights
13th Sep 20242:51 pmRNSGrant of Share Options to French Senior Management
12th Sep 20244:31 pmRNSPDMR Exercise of Share Options
3rd Sep 20242:15 pmRNSAppointment To Remuneration Committee
2nd Sep 20245:00 pmRNSTotal Voting Rights
29th Aug 20242:45 pmRNSPDMR Shareholding notification
12th Aug 20245:30 pmRNSGrant of Share Options
31st Jul 20245:29 pmRNSTotal Voting Rights
25th Jul 20245:45 pmRNSGrant of Options to Directors
23rd Jul 20242:57 pmRNSEGM Voting results announcement
23rd Jul 20242:15 pmRNSAGM 2024 Voting results announcement
16th Jul 20244:56 pmRNSBlock listing six monthly return
16th Jul 20247:00 amRNSQ1 FY25 Trading Update
19th Jun 20247:00 amRNSNotice of AGM and EGM
17th Jun 202410:00 amRNSGrant of Share Options
13th Jun 20244:50 pmRNSNotice of FY25 Q1 Trading Statement
7th Jun 20243:25 pmRNSPDMR Purchase of Shares
5th Jun 20247:05 amRNSAppointment of new Chair
5th Jun 20247:00 amRNSFY24 Preliminary Results
29th May 20242:30 pmRNSDirector Appointment & Results of OGM
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.